As the world continues to battle the COVID-19 pandemic, pharmaceutical giants like Pfizer are making groundbreaking moves to help the global population combat this deadly virus. Pfizer, in particular, has been at the forefront of developing a vaccine against COVID-19 that has been shown to be highly effective against the virus.
Pfizer`s COVID-19 vaccine has been approved by various regulatory agencies across the world and has become the most sought-after vaccine. However, many people may not be aware of the various agreements that Pfizer has entered into in order to make their vaccine available to as many people as possible.
One of the most important agreements that Pfizer has entered into is with the United States government. In July 2020, the U.S. government entered into a $1.95 billion agreement with Pfizer to procure 100 million doses of their COVID-19 vaccine. This agreement also has an option for the U.S. government to acquire an additional 500 million doses of the vaccine.
This agreement with the U.S. government is just one of the many agreements that Pfizer has entered into. Pfizer has also reached agreements with various governments across the world, including those of the United Kingdom, Canada, and Japan, among others. These agreements are all geared towards ensuring that as many people as possible have access to the vaccine.
Apart from agreements with various governments, Pfizer has also entered into partnerships with various organizations to help with the distribution of the vaccine. For example, Pfizer has partnered with BioNTech and the World Health Organization (WHO) to help distribute the vaccine to low-income countries across the world.
In addition to these agreements, Pfizer has also entered into agreements with other pharmaceutical companies to help with the manufacturing of the vaccine. One such agreement is with the Indian pharmaceutical company, Biocon, which has been tasked with manufacturing the drug substance for Pfizer`s COVID-19 vaccine.
In conclusion, Pfizer`s COVID-19 vaccine is currently the most sought-after vaccine across the world, and Pfizer has entered into various agreements to ensure that the vaccine is available to as many people as possible. From agreements with various governments to partnerships with organizations like the WHO, Pfizer is doing all it can to help bring an end to this pandemic.